Citius Pharmaceuticals (NASDAQ:CTXR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Citius Pharmaceuticals (CTXR) operate in?

Citius Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Citius Pharmaceuticals Stock (NASDAQ: CTXR) stock price, news, charts, stock research, profile.

Open	$2.65
Close	$2.67
Volume / Avg.	54.01K / 288.95K
Day Range	$2.58 - $2.75
52 Wk Range	2.44 - 26.75
Market Cap	$21.93M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	7.25%
Days to Cover	4.26

Recent News

Why Citius Pharmaceuticals (CTXR) Stock Is Down 15%

Citius Pharmaceuticals shares are trading lower by 15% during Wednesday's session. The company announced a $3 million registered direct offering.

Henry Khederian

This American Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday

Avi Kapoor

US Stock Futures Slip After Friday's Fall: 'Santa Rally' In Doubt? Analyst Calls It A Bit Of Profit-Taking

U.S. stock futures declined on Monday after ending lower on Friday. All four index futures slipped in trade.

Rishabh Mishra

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.65
Close	$2.67
Volume / Avg.	54.01K / 288.95K
Day Range	$2.58 - $2.75
52 Wk Range	2.44 - 26.75
Market Cap	$21.93M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	7.25%
Days to Cover	4.26

About Citius Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Citius Pharmaceuticals (CTXR) stock?

You can purchase shares of Citius Pharmaceuticals (NASDAQ:CTXR) through any online brokerage.

View our list of the best stock brokerages

Who are Citius Pharmaceuticals (CTXR) competitors?

Other companies in Citius Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Lipocine (NASDAQ:LPCN).

What is the forecast, or price target, for Citius Pharmaceuticals (CTXR) stock?

Citius Pharmaceuticals has a consensus price target of $6.33.

What is the current price for Citius Pharmaceuticals (CTXR)?

The stock price for Citius Pharmaceuticals (NASDAQ: CTXR) is $2.5518 last updated February 7, 2025 at 4:26 PM EST.

Does Citius Pharmaceuticals (CTXR) pay a dividend?

There are no upcoming dividends for Citius Pharmaceuticals.

When is Citius Pharmaceuticals (NASDAQ:CTXR) reporting earnings?

Citius Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, February 18, 2025.

Is Citius Pharmaceuticals (CTXR) going to split?

There is no upcoming split for Citius Pharmaceuticals.

What sector and industry does Citius Pharmaceuticals (CTXR) operate in?

Citius Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Citius Pharmaceuticals

Citius Pharmaceuticals (CTXR) Forecast